Pressmeddelanden, rapporter och bolagsmeddelande för Curasight
Spotlight News
Nyhetsuppdatering från Curasight
Press release from Companies: Curasight A/S announces outcome of warrant exercise
Spotlight News
Nyhetsuppdatering från Curasight
Press release from Companies: SEB maintain valuation range midpoint at DKK 54 per share
Spotlight News
Nyhetsuppdatering från Curasight
Press release from Companies: SEB maintain valuation range midpoint at DKK 54 per share
Spotlight News
Nyhetsuppdatering från Curasight
Press release from Companies: The last day of trading in warrants of series TO2 is on the 3[rd] of December 2024
Spotlight News
Nyhetsuppdatering från Curasight
Press release from Companies: Curasight and Curium sign global radioisotope supply agreement for uTREAT[®]
Spotlight News
Nyhetsuppdatering från Curasight
Press release from Companies: The exercise period for warrants of series TO2 commences today
Spotlight News
Nyhetsuppdatering från Curasight
Reports: Interim report Q3 2024
Spotlight News
Nyhetsuppdatering från Curasight
Press release from Companies: The exercise price for warrants of series TO2 has been set to DKK 11.50 per new share
Spotlight News
Nyhetsuppdatering från Curasight
Press release from Companies: Curasight to present at HC Andersen Capital, BioStock Life Science Summit 2024, and Økonomisk Ugebrev Investor Conference
Spotlight News
Nyhetsuppdatering från Curasight
Press release from Companies: Curasight announces international patent application for uTREAT® to broaden IP protection